Portrait Gerd-Achim Kullak-Ublick

Gerd-Achim Kullak-Ublick
Prof.

Director of Department, Department of Clinical Pharmacology and Toxicology

Specialties

  • FMH Internal Medicine
  • FMH Gastroenterology
  • FMH Clinical Pharmacology and Toxicology

Contact

Tel. +41 44 255 20 68

Other competencies

  • 2019 – Head of Work Package 2 “Drug-induced liver injury” (DILI) and academic coordinator of the IMI TransBioLine Consortium (Translational Safety Biomarker Pipeline) of the European Union
  • 2018 – Pro-Euro DILI Network (Prof. Gerd A Kullak Ublick. | PRO-EURO DILI NETWORK)
  • 2008 – 2011: Member of the Federal Drug Commission, Federal Ministry of Health, Bern / Switzerland
  • 2013 – Member of the jury for the annual Paul Martini Prize (Paul Martini Foundation)

Career

since 2006 Professor, Director of the Department of Clinical Pharmacology and Toxicology, University Hospital Zurich
2001 – 2006 SNSF Professorship, Department of Clinical Pharmacology and Toxicology and Department of Gastroenterology and Hepatology, University Hospital Zurich
1999 – 2001 Attending Physician Hepatology, Department of Clinical Pharmacology and Toxicology and Department of Gastroenterology and Hepatology, University Hospital Zurich
1998 – 2005 Specialist certification in internal medicine with a focus on gastroenterology, as well as clinical pharmacology and toxicology
1992 – 1994 Postdoctoral fellow in the Department of Clinical Pharmacology and Toxicology, University Hospital Zurich in collaboration with the Liver Center, Albert Einstein College of Medicine, Bronx/New York
1991 – 1999 Resident at the Medical Clinic II, Grosshadern Hospital, University of Munich/Germany
1991 Dissertation on “Mechanisms of action of plant sterols on the inhibition of cholesterol absorption: comparison of sitosterol and sitostanol” at the Department of Clinical Pharmacology at the University of Bonn/Germany
1990 State Examination in Human Medicine, University of Munich / Germany
1984 – 1990 Medical studies, Universities of Bonn, Munich, London (UK) and Stanford (USA)
1983 General Certificate of Education (GCE), Oxford and Cambridge Examinations Board, St. Paul’s School, London/England

Most important memberships

  • Co-Chair of the Dissertation Committee, Faculty of Medicine, University of Zurich
  • Member of the University Competence Center “Biomedical Ethics and Law” (MER)
  • Member of the PhD program “Drug Discovery” (UZH – Drug Discovery Network Zurich)
  • Member of the PhD program “BioMed” (UZH – PhD Program Biomedicine)
  • Swiss Society for Clinical Pharmacology and Toxicology (SSCPT)
  • Swiss Society of General Internal Medicine (SGAIM – SSMIG – SSGIM)
  • Investigator of the Swiss Society for the Study of the Liver
  • NCCR Kidney (National Competence Center for Research)
  • Zurich Center for Integrative Human Physiology
  • Member of the Scientific Committee of the Swiss IBD Cohort Study

Membership of international professional organizations

  • American Association for the Study of Liver Diseases
  • Pro-Euro DILI Registry (PRO-EURO DILI NETWORK | Prospective European Drug-Induced Liver Injury Network)
  • International Serious Adverse Event Consortium (International Serious Adverse Event Consortium (iSAEC) | Columbia University Department of Systems Biology) in the context of the IDILIC study (International Drug-Induced Liver Injury Consortium) at Newcastle University, UK
  • IQ DILI Consortium